![Darius Kharabi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darius Kharabi
Corporate Officer/Principal chez
KALA BIO, INC.
Fortune : 446 $ au 30/06/2026
Profil
Darius Kharabi is a co-founder of Lagunita and is co-founder, President & CEO of Combangio.
He is a Board member of Combangio and Kedalion Therapeutics.
Mr. Kharabi focuses on company creation at Lagunita and previously served as executive management for xCella and Kedalion, helping to build early value, raise financing and recruit full-time leadership teams.
Prior to Lagunita, he served as Vice President, Corporate Development and International Sales at OrthAlign Inc., a commercial stage orthopedic surgery navigation company, where his responsibilities included the launch of the KneeAlign® total knee arthroplasty navigation product line in North America, Europe, Asia and Australia.
Mr. Kharabi started his career as a biotechnology licensing attorney at Wilson, Sonsini Goodrich & Rosati PC.
He received his B.S.
in Biochemistry from Georgetown University and his J.D.
and M.B.A. degrees from Stanford University
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/10/2025 | 258 ( 0 % ) | 446 $ | 30/06/2026 |
Postes actifs de Darius Kharabi
| Sociétés | Poste | Début |
|---|---|---|
| KALA BIO, INC. | Corporate Officer/Principal | 15/11/2021 |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic drug company which manufactures and delivers topical drugs | Directeur/Membre du Conseil | 01/11/2017 |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes immuno-oncology antibody therapeutics | Directeur Général | 01/08/2019 |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions. | Fondateur | - |
Anciens postes connus de Darius Kharabi
| Sociétés | Poste | Fin |
|---|---|---|
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company which develops regenerative bio-therapeutics for severe ocular diseases | Directeur Général | 01/12/2021 |
OrthAlign Corp.
 OrthAlign Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Corporate Officer/Principal | 28/09/2011 |
Formation de Darius Kharabi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrthAlign Corp.
OrthAlign Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions. | Finance |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic drug company which manufactures and delivers topical drugs | Health Technology |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes immuno-oncology antibody therapeutics | Health Technology |
Combangio, Inc.
Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company which develops regenerative bio-therapeutics for severe ocular diseases | Commercial Services |
